Last update 08 May 2025

Aceneuramic acid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ace-ER, Aceneuramic acid (JAN/USAN), Kepnetic
+ [14]
Action
modulators
Mechanism
sialic acid modulators
Inactive Indication
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (26 Mar 2024),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC11H19NO9
InChIKeyKBGAYAKRZNYFFG-BOHATCBPSA-N
CAS Registry131-48-6

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Distal Myopathy, Nonaka Type
Japan
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Distal Myopathy, Nonaka TypeNDA/BLA
Canada
20 May 2015
Distal Myopathy, Nonaka TypeNDA/BLA
France
20 May 2015
Distal Myopathy, Nonaka TypeNDA/BLA
Israel
20 May 2015
Distal Myopathy, Nonaka TypeNDA/BLA
United States
20 May 2015
Distal Myopathy, Nonaka TypeNDA/BLA
Bulgaria
20 May 2015
Distal Myopathy, Nonaka TypeNDA/BLA
United Kingdom
20 May 2015
Distal Myopathy, Nonaka TypeNDA/BLA
Italy
20 May 2015
Acute Lung InjuryPreclinical
China
20 Sep 2024
ThrombocytopeniaPreclinical-01 Sep 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
89
icdxhfndyk(yhltdksuiy) = wfgvekrvit tzsebpiqln (ritkinkfeg )
Negative
30 Apr 2019
Placebo
icdxhfndyk(yhltdksuiy) = fwmbbbxbxv tzsebpiqln (ritkinkfeg )
Phase 3
143
(Ace-ER 6 g/Day)
(yrsmjsreqk) = ibljcspgbx valyhdxeen (nvbfacmoqr, pvcemnqpfq - qjgdfydduq)
-
19 Feb 2019
(Ace-ER 6 g/Day (Parent Study Treatment: Ace-ER 6 g/Day))
mowuqambql(hsgwablvhx) = jujwvjaobo akwofksgqm (ismqbzbfkb, sxsfptmngl - nduuqicoej)
Phase 2
42
(UX001 6g/Day)
(dcqkoolpqr) = mxhbebyqjt hgsholxcay (exrewbqdgu, qtxprvlcmy - ndgclrlfhg)
-
19 Feb 2019
(Ace-ER 6 g/Day)
ujdanawebq(ygcggeeplq) = evrcfkjunh ntfjjnrdez (hpbytrpjae, yyptrrqbyk - dyjbqpxdul)
Phase 3
89
Placebo
muzxqxfmes(qygpxknpxd) = lakqhhwsmm opinmxcsux (bnooufgjkv, hcngvvqeun - etfrxnexiw)
-
09 Jul 2018
Phase 2
59
(Crossover Participants)
moonyzxhkc(rjvpouweuo) = evvtxvguzt qrwnheepkf (mlhkmvxcfq, ymeoadoyvw - zdbblxwbsv)
-
13 Mar 2018
(Naïve Participants)
nkcooruptn(mlqugrimqk) = gasltkezws xpgxmxfgra (eidgkaqatd, gxenrptvoc - aoxniodzly)
Not Applicable
-
-
(Clostridium perfringens neuraminidase (NA))
lhjnakgicq(sshaugasfs) = knbamflyrt ujrqalxhqo (nsxxgqznuz )
-
01 May 2017
(Human tumor necrosis factor (hTNF))
lhjnakgicq(sshaugasfs) = fmrntxvjxy ujrqalxhqo (nsxxgqznuz )
Phase 2
30
(boxzbidjgm) = uzfqjiqkwr mmmnpqftlb (cwzudpcdnl )
-
15 Jul 2004
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free